AVSF - Juvena Therapeutics 2022, LLC is a venture capital fund based in Boston, Massachusetts. According to its most recent Form D, filed Jun 16, 2022, it has sold $614,000 of interests to 32 investors since its first sale in Jun 2022. The minimum investment it accepts from an outside investor is $25,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Michael Collins.
- Total raised
- $614,000Cumulative sales reported on Form D
- Investors
- 32
- First sale
- Jun 2, 2022
- Minimum investment
- $25,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Michael Collins
- Latest Form D
- Jun 16, 2022
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about AVSF - Juvena Therapeutics 2022, LLC
What is the minimum investment for AVSF - Juvena Therapeutics 2022, LLC?
According to its latest Form D, filed Jun 16, 2022, the minimum investment AVSF - Juvena Therapeutics 2022, LLC accepts from an outside investor is $25,000.
Who can invest in AVSF - Juvena Therapeutics 2022, LLC?
AVSF - Juvena Therapeutics 2022, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has AVSF - Juvena Therapeutics 2022, LLC raised?
AVSF - Juvena Therapeutics 2022, LLC reports $614,000 sold from 32 investors on its Form D filed Jun 16, 2022. This is cumulative sales since the offering began, not current assets or performance.
Where is AVSF - Juvena Therapeutics 2022, LLC based?
AVSF - Juvena Therapeutics 2022, LLC is based in Boston, Massachusetts.
When did AVSF - Juvena Therapeutics 2022, LLC launch?
AVSF - Juvena Therapeutics 2022, LLC reports its first sale in Jun 2022.
Size compared with every venture capital fund
Raised more than 55% of the 535 venture capital funds based in Massachusetts, and more than 52% of all 14,864 that report sales.